Literature DB >> 6126784

Intracavernous injection of papaverine for erectile failure.

R Virag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6126784     DOI： 10.1016/s0140-6736(82)90910-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  59 in total

Review 1.  Topical agents and erectile dysfunction: is there a place?

Authors:  Ronald L Yap; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2002-12       Impact factor: 3.092

Review 2.  Drugs for the treatment of impotence.

Authors:  L Garcia-Reboll; J P Mulhall; I Goldstein
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

3.  Extending the rationale of combination therapy to unresponsive erectile dysfunction.

Authors:  Christopher Reece; Rajeev Kumar; Diedre Nienow; Ajay Nehra
Journal:  Rev Urol       Date:  2007

4.  Hemodynamic effects of sildenafil citrate (Viagra) on segmental branches of bilateral renal arteries.

Authors:  Arslan Ardicoglu; Ercan Kocakoc; Veysel Yuzgec; Zulkif Bozgeyik; Halit Canatan; Adem Kiris
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 5.  Medical treatment of erectile dysfunction.

Authors:  N Burns-Cox; C Gingell
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

Review 6.  Androgens are fundamental in the maintenance of male sexual health.

Authors:  Alvaro Morales
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 7.  Intracavernous prostaglandin E1 in erectile dysfunction.

Authors:  O I Linet; L L Neff
Journal:  Clin Investig       Date:  1994-01

8.  Toxicity assessment of papaverine hydrochloride and papaverine-derived metabolites in primary cultures of rat hepatocytes.

Authors:  J C Davila; C G Reddy; P J Davis; D Acosta
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

Review 9.  Drug-induced male sexual dysfunction. An update.

Authors:  G B Brock; T F Lue
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

10.  A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model.

Authors:  I Gozes; M Fridkin
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.